FAIRsharing is now available for record creation, update, and search at https://beta.fairsharing.org, please visit us there! This read-only version of the legacy site will be replaced with the new version of FAIRsharing in the coming weeks.

International Classification of Diseases for Oncology, 3rd Edition

Abbreviation: ICD-O-3

General Information

The International Classification of Diseases for Oncology, 3rd Edition (ICD-O-3) is used principally in tumour or cancer registries for coding the site (topography) and the histology (morphology) of neoplasms, usually obtained from a pathology report. It provides a multi-axial classification of the site, morphology, behaviour, and grading of neoplasms. The topography axis uses the ICD-10 classification of malignant neoplasms (except those categories which relate to secondary neoplasms and to specified morphological types of tumours) for all types of tumours, thereby providing greater site detail for non-malignant tumours than is provided in ICD-10. In contrast to ICD-10, the ICD-O-3 includes topography for sites of haematopoietic and reticuloendothelial tumours.

Homepage https://www.who.int/standards/classifications/other-classifications/international-classification-of-diseases-for-oncology

Countries that developed this resource Worldwide

Created in 1976

Taxonomic range

Homo sapiens

Knowledge Domains

Subjects

How to cite this record FAIRsharing.org: ICD-O-3; International Classification of Diseases for Oncology, 3rd Edition; DOI: https://doi.org/10.25504/FAIRsharing.mtf81z; Last edited: March 26, 2021, 2:41 p.m.; Last accessed: Oct 16 2021 4:56 p.m.

Record updated: March 25, 2021, 3:32 p.m. by The FAIRsharing Team.

Show edit history

Edits to 'https://fairsharing.org/FAIRsharing.mtf81z' by 'The FAIRsharing Team' at 15:32, 25 Mar 2021 (approved):

	'organizations' has been modified:
		Before:
			International Agency for Research on Cancer (IARC), Lyon, France|http://www.iarc.fr|Maintains
		After:
			International Agency for Research on Cancer (IARC), Lyon, France|http://www.iarc.fr|Maintains
			World Health Organization (WHO)|http://www.who.int/|Maintains
		Added:
			World Health Organization (WHO)|http://www.who.int/|Maintains
		Removed:

	'supportLinks' has been modified:
		Before:
			twitter|@IARCWHO
			wikipedia|https://en.wikipedia.org/wiki/International_Classification_of_Diseases_for_Oncology
		After:
			email|jakobr@who.int
			wikipedia|https://en.wikipedia.org/wiki/International_Classification_of_Diseases_for_Oncology
		Added:
			email|jakobr@who.int
		Removed:
			twitter|@IARCWHO

	'name' has been modified:
		Before: International Classification of Diseases for Oncology 3rd Revision
		After: International Classification of Diseases for Oncology, 3rd Edition

	'licences' has been modified:
		Before:
		After:
			World Health Organization (WHO) Copyright, Licencing and Permissions|https://www.who.int/about/who-we-are/publishing-policies/copyright|Data
			ICD-O: account required for non-commercial download|http://apps.who.int/classifications/apps/icd/ClassificationDownload/DLArea/Download.aspx|Data
			ICD-O: Commercial use requires licence agreement|http://apps.who.int/classifications/apps/icd/ClassificationDownload/DLArea/Download.aspx|Data
		Added:
			World Health Organization (WHO) Copyright, Licencing and Permissions|https://www.who.int/about/who-we-are/publishing-policies/copyright|Data
			ICD-O: account required for non-commercial download|http://apps.who.int/classifications/apps/icd/ClassificationDownload/DLArea/Download.aspx|Data
			ICD-O: Commercial use requires licence agreement|http://apps.who.int/classifications/apps/icd/ClassificationDownload/DLArea/Download.aspx|Data
		Removed:

	'yearOfCreation' has been modified:
		Before: 2000
		After: 1976

	'onto_domains' has been modified:
		Before:
			Classification
			Neoplasm
			cancer
			disease
			histological assay
			morphology
		After:
			Classification
			Electronic Health Record
			Neoplasm
			cancer
			disease
			histological assay
			morphology
		Added:
			Electronic Health Record
		Removed:

	'contactEmail' has been modified:
		Before: iacr@iarc.fr
		After: brayf@who.int

	'contact' has been modified:
		Before: IACR General Enquiries
		After: Freddie Bray

	'dataProcesses' has been modified:
		Before:
			ICD-O-3 Specification, data release, https://apps.who.int/iris/handle/10665/42344
		After:
			Download, data release, https://apps.who.int/iris/handle/10665/42344
			Download (Login required), data release, http://apps.who.int/classifications/apps/icd/ClassificationDownload/DLArea/Download.aspx
		Added:
			Download, data release, https://apps.who.int/iris/handle/10665/42344
			Download (Login required), data release, http://apps.who.int/classifications/apps/icd/ClassificationDownload/DLArea/Download.aspx
		Removed:
			ICD-O-3 Specification, data release, https://apps.who.int/iris/handle/10665/42344

	'shortname' has been modified:
		Before: ICD-0-3
		After: ICD-O-3

	'homepage' has been modified:
		Before: http://www.iacr.com.fr/index.php?option=com_content&view=category&layout=blog&id=100&Itemid=577
		After: https://www.who.int/standards/classifications/other-classifications/international-classification-of-diseases-for-oncology

	'description' has been modified:
		Before: The International Classification of Diseases for Oncology (ICD-0) has been used for nearly 25 years,
principally in tumor or cancer registries, for coding the site (topography) and the histology (morphology)
of the neoplasm, usually obtained from a pathology report. ICD-0 is a dual classification with coding systems for both topography and morphology. The topography code describes the site of origin of the neoplasms and uses the same 3-character and 4-character categories as ICD-10 for malignant neoplasms (COO-C80); this allows greater specificity for coding sites of nonmalignant neoplasms than is possible in ICD-10. The morphology code describes the cell type of the tumor and its biological activity, in other words, the characteristics of the tumor itself.
		After: The International Classification of Diseases for Oncology, 3rd Edition (ICD-O-3) is used principally in tumour or cancer registries for coding the site (topography) and the histology (morphology) of neoplasms, usually obtained from a pathology report. It provides a multi-axial classification of the site, morphology, behaviour, and grading of neoplasms. The topography axis uses the ICD-10 classification of malignant neoplasms (except those categories which relate to secondary neoplasms and to specified morphological types of tumours) for all types of tumours, thereby providing greater site detail for non-malignant tumours than is provided in ICD-10. In contrast to ICD-10, the ICD-O-3 includes topography for sites of haematopoietic and reticuloendothelial tumours.

Edits to 'https://fairsharing.org/FAIRsharing.mtf81z' by 'The FAIRsharing Team' at 13:02, 23 Jan 2020 (approved):

	'dataProcesses' has been modified:
		Before:
		After:
			ICD-O-3 Specification
		Added:
			ICD-O-3 Specification
		Removed:

Edits to 'https://fairsharing.org/FAIRsharing.mtf81z' by 'The FAIRsharing Team' at 13:01, 23 Jan 2020 (approved):

	'organizations' has been modified:
		Before:
			International Agency for Research on Cancer (IARC), Lyon, France|http://www.iarc.fr|Maintains
			World Health Organization (WHO)|http://www.who.int/|Maintains
		After:
			International Agency for Research on Cancer (IARC), Lyon, France|http://www.iarc.fr|Maintains
		Added:
		Removed:
			World Health Organization (WHO)|http://www.who.int/|Maintains

	'supportLinks' has been modified:
		Before:
			twitter|@IARCWHO
		After:
			twitter|@IARCWHO
			wikipedia|https://en.wikipedia.org/wiki/International_Classification_of_Diseases_for_Oncology
		Added:
			wikipedia|https://en.wikipedia.org/wiki/International_Classification_of_Diseases_for_Oncology
		Removed:

	'name' has been modified:
		Before: ICD_Oncology-3
		After: International Classification of Diseases for Oncology 3rd Revision

	'onto_disciplines' has been modified:
		Before:
			Biomedical Science
			Oncology
		After:
			Global Health
			Health Science
			Oncology
			Pathology
		Added:
			Global Health
			Health Science
			Pathology
		Removed:
			Biomedical Science

	'related_standards' has been modified:
		Before:
		After:
			International Classification of Diseases Version 10
			Systematized Nomenclature of Medicine-Clinical Terms
		Added:
			International Classification of Diseases Version 10
			Systematized Nomenclature of Medicine-Clinical Terms
		Removed:

	'onto_domains' has been modified:
		Before:
			Classification
			cancer
			device
		After:
			Classification
			Neoplasm
			cancer
			disease
			histological assay
			morphology
		Added:
			Neoplasm
			disease
			histological assay
			morphology
		Removed:
			device

	'contactEmail' has been modified:
		Before: cin@iarc.fr
		After: iacr@iarc.fr

	'contact' has been modified:
		Before: General Enquiries
		After: IACR General Enquiries

	'miriam_id' has been modified:
		Before: None
		After: 

	'shortname' has been modified:
		Before: ICD-O-3
		After: ICD-0-3

	'homepage' has been modified:
		Before: http://codes.iarc.fr
		After: http://www.iacr.com.fr/index.php?option=com_content&view=category&layout=blog&id=100&Itemid=577

	'description' has been modified:
		Before: Classification of Diseases for Oncology (ICD-O) has been internationally recognized as the definitive classification of neoplasms. It is used by cancer registries throughout the world to record incidence of malignancy and survival rates, and the data produced are used to inform cancer control, research activity, treatment planning and health economics.
		After: The International Classification of Diseases for Oncology (ICD-0) has been used for nearly 25 years,
principally in tumor or cancer registries, for coding the site (topography) and the histology (morphology)
of the neoplasm, usually obtained from a pathology report. ICD-0 is a dual classification with coding systems for both topography and morphology. The topography code describes the site of origin of the neoplasms and uses the same 3-character and 4-character categories as ICD-10 for malignant neoplasms (COO-C80); this allows greater specificity for coding sites of nonmalignant neoplasms than is possible in ICD-10. The morphology code describes the cell type of the tumor and its biological activity, in other words, the characteristics of the tumor itself.

Edits to 'https://fairsharing.org/FAIRsharing.mtf81z' by 'The FAIRsharing Team' at 19:29, 07 Nov 2016 (approved):

	'description' has been modified:
		Before: "ICD_Oncology-3" is a standard, specialising in the fields described under "scope and data types", below. Until this entry is claimed, more information on this project can be found at http://bioportal.bioontology.org/ontologies/1670. This text was generated automatically. If you work on the project responsible for "ICD_Oncology-3" then please consider helping us  by claiming this record  and updating it appropriately.
		After: Classification of Diseases for Oncology (ICD-O) has been internationally recognized as the definitive classification of neoplasms. It is used by cancer registries throughout the world to record incidence of malignancy and survival rates, and the data produced are used to inform cancer control, research activity, treatment planning and health economics.

Edits to 'https://fairsharing.org/FAIRsharing.mtf81z' by 'The FAIRsharing Team' at 19:24, 07 Nov 2016 (approved):

	'homepage' has been modified:
		Before: http://bioportal.bioontology.org/ontologies/1670
		After: http://codes.iarc.fr

In Collections

RDA Covid-19 WG Resources

Support

General

support email	Robert Jakob
wikipedia	ICD-0 Wikipedia entry

Additional Information

Contact

Freddie Bray

Tools

No tools defined

Schemas

No XSD schemas defined

Access / Retrieve Data

Conditions of Use

Applies to: Data use

Data Release

Download	https://apps.who.int/iris/handle/10665/42344
Download (Login required)	http://apps.who.int/classifications/apps/icd/ClassificationDownload/DL ...

Publications

No publications available

Related Standards

Reporting Guidelines

No guidelines defined

Terminology Artifacts

Models and Formats

No syntax standards defined

Identifier Schemas

No identifier schema standards defined

Metrics

No metrics standards defined

Related Databases (2)

Progenetix - genomic copy number aberrations in cancer
The Progenetix database provides an overview of copy number abnormalities in human cancer from Comparative Genomic Hybridization (CGH) experiments. With 30817 cases from 1016 publications (Oct 2013), Progenetix is the largest curated database for whole genome CGH profiles. The current dataset contains 20621 chromosomal CGH and 10302 profiles from genomic array experiments. This data covers 365 diagnostic entities according to the International Classification of Disease in Oncology (ICD-O 3). Additionally, the website attempts to lists all publications referring to cancer genome profiling experiments.

arrayMap - Genomic Array Data for Cancer CNV Profiles
Part of the Progenetix project, the arrayMap database facilitates the study of the genetics of human cancer. The Progenetix project provides the data customisation and visualization tools to mine the available data. The arrayMap database is developed by the group "Theoretical Cytogenetics and Oncogenomics" at the Department of Molecular Life Sciences of the University of Zurich.

Implementing Policies

This record is not implemented by any policy.

Credit

Record Maintainer

This record is in need of a maintainer. If you login, you'll be able to claim this record.

Maintains

International Agency for Research on Cancer (IARC), Lyon, France (Government body)
World Health Organization (WHO) (Government body)

International Classification of Diseases for Oncology, 3rd Edition

We need your help!

Developed by

Contact Us

About FAIRsharing